Revvity, Inc. (NYSE:RVTY) Shares Sold by 2Xideas AG

2Xideas AG lowered its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 38.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 88,381 shares of the company's stock after selling 54,263 shares during the quarter. 2Xideas AG owned about 0.07% of Revvity worth $9,864,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in RVTY. FMR LLC grew its position in Revvity by 40.8% during the third quarter. FMR LLC now owns 155,556 shares of the company's stock worth $19,872,000 after buying an additional 45,040 shares in the last quarter. Public Sector Pension Investment Board grew its holdings in shares of Revvity by 14.9% during the third quarter. Public Sector Pension Investment Board now owns 5,383 shares of the company's stock worth $688,000 after purchasing an additional 700 shares in the last quarter. Investment Management Corp of Ontario increased its position in shares of Revvity by 46.3% in the third quarter. Investment Management Corp of Ontario now owns 4,107 shares of the company's stock worth $525,000 after purchasing an additional 1,300 shares during the last quarter. Quantinno Capital Management LP raised its stake in Revvity by 62.7% in the third quarter. Quantinno Capital Management LP now owns 43,692 shares of the company's stock valued at $5,582,000 after purchasing an additional 16,834 shares in the last quarter. Finally, State Street Corp lifted its position in Revvity by 0.3% during the third quarter. State Street Corp now owns 5,180,169 shares of the company's stock valued at $661,767,000 after purchasing an additional 17,832 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

Remove Ads

Analyst Ratings Changes

RVTY has been the subject of a number of research reports. KeyCorp upped their price objective on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Bank of America raised shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 target price on the stock in a research report on Friday, December 13th. Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a research report on Friday, January 10th. Barclays cut their target price on Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research note on Thursday. Finally, Raymond James restated an "outperform" rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $133.75.

Revvity Stock Performance

Shares of Revvity stock traded up $1.93 during midday trading on Friday, hitting $94.95. The company had a trading volume of 1,159,130 shares, compared to its average volume of 889,528. The stock has a market cap of $11.41 billion, a price-to-earnings ratio of 42.59, a PEG ratio of 3.82 and a beta of 1.07. Revvity, Inc. has a 12-month low of $89.61 and a 12-month high of $129.50. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The company has a fifty day simple moving average of $109.69 and a 200 day simple moving average of $115.36.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the business posted $1.25 earnings per share. As a group, analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.29%. Revvity's dividend payout ratio (DPR) is presently 12.67%.

Insider Activity

In other news, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares in the company, valued at $4,232,782. The trade was a 31.23 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.68% of the company's stock.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.